Secondary sclerosing cholangitis in critically ill patients: model of end-stage liver disease score and renal function predict outcome

Endoscopy. 2012 Nov;44(11):1055-8. doi: 10.1055/s-0032-1325733. Epub 2012 Oct 29.

Abstract

Secondary sclerosing cholangitis in critically ill patients (SSC - CIP) is an underdiagnosed emerging disease. The aim of this study was to characterize clinical features and prognostic factors for mortality in SSC - CIP. This retrospective study included 54 patients who were diagnosed via endoscopic retrograde cholangiopancreatography (ERCP) after cardiothoracic surgery (n = 21), sepsis (n = 13), polytrauma (n = 11), and others (n = 9). In total, 33 patients who either died (n = 27) or needed liver transplantation (n = 6) were compared with surviving patients (n = 21). The model for end-stage liver disease (MELD) score and need for renal replacement therapy were independent risk factors for mortality. Compared with ERCP, accuracy was 30% for ultrasound and 36 % for liver biopsies. As a result of microbiological bile analysis, 28 % of patients required a change in antibiotic treatment. SSC - CIP is frequently a fatal disease. ERCP should be considered in selected patients to establish the diagnosis and hence provide useful clinical information.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Bile / microbiology
  • Cholangiopancreatography, Endoscopic Retrograde*
  • Cholangitis, Sclerosing / diagnosis
  • Cholangitis, Sclerosing / etiology*
  • Cholangitis, Sclerosing / mortality*
  • Critical Illness*
  • End Stage Liver Disease / diagnosis
  • Humans
  • Kidney / physiopathology*
  • Middle Aged
  • Prognosis
  • Proportional Hazards Models
  • Retrospective Studies
  • Risk Factors
  • Severity of Illness Index